App Dealroom

Published September 23, 2026

iX Biopharma secures $41M DoD funding for Wafermine ketamine wafer and spins off ...

Read the full story at App Dealroom

iX Biopharma has secured US$41 million in Department of Defense funding for Phase 3 studies of Wafermine, its sublingual ketamine wafer targeting.